This paper describes the drug discovery and development pipeline in Section 2 before a more detailed discussion of the impact of technology on the pipeline stages in Section 3. Section 4 identifies the expertise and capabilities in Australia that can contribute at different stages and where there are deficiencies. Section 5 concludes with a discussion of where Australia might concentrate its effort to enable a better participation in the global industry
Nanotechnology is the latest in a series of general purpose technologies (GPT), earlier examples of ...
The Australian chemical industry is facing a testing period as it adjusts to the challenges of the n...
The Australian chemical industry continues to face testing times in adjusting to the challenges of g...
This paper describes the drug discovery and development pipeline in Section 2 before a more detailed...
The purpose of this paper is to examine possible development paths for Australia's indigenous\ud bio...
The purpose of this paper is to examine possible development paths for Australia's indigenous biome...
This paper provides an overview of the Australian and global pharmaceuticals industries, a discussio...
This paper outlines trends in the development of high-profile new technologies such as nano- and bio...
In Australia, regulation of the pharmaceutical sector is falling in thrall of the idea of innovation...
The chemical industry plays an important part in modern economies and in national innovation systems...
Technology and Australia’s Future examines how technology has changed in the past, how it will conti...
The changing global environment presents a number of challenges and opportunities for the Australian...
The pharmaceutical industry is highly complex. The technologies leading to drug discovery and devel...
The Australian chemical industry is facing a testing period as it adjusts to the challenges of the n...
The pharmaceutical industry is highly complex. The technologies leading to drug\ud discovery and dev...
Nanotechnology is the latest in a series of general purpose technologies (GPT), earlier examples of ...
The Australian chemical industry is facing a testing period as it adjusts to the challenges of the n...
The Australian chemical industry continues to face testing times in adjusting to the challenges of g...
This paper describes the drug discovery and development pipeline in Section 2 before a more detailed...
The purpose of this paper is to examine possible development paths for Australia's indigenous\ud bio...
The purpose of this paper is to examine possible development paths for Australia's indigenous biome...
This paper provides an overview of the Australian and global pharmaceuticals industries, a discussio...
This paper outlines trends in the development of high-profile new technologies such as nano- and bio...
In Australia, regulation of the pharmaceutical sector is falling in thrall of the idea of innovation...
The chemical industry plays an important part in modern economies and in national innovation systems...
Technology and Australia’s Future examines how technology has changed in the past, how it will conti...
The changing global environment presents a number of challenges and opportunities for the Australian...
The pharmaceutical industry is highly complex. The technologies leading to drug discovery and devel...
The Australian chemical industry is facing a testing period as it adjusts to the challenges of the n...
The pharmaceutical industry is highly complex. The technologies leading to drug\ud discovery and dev...
Nanotechnology is the latest in a series of general purpose technologies (GPT), earlier examples of ...
The Australian chemical industry is facing a testing period as it adjusts to the challenges of the n...
The Australian chemical industry continues to face testing times in adjusting to the challenges of g...